Table: begin end state 1 19 cytoplasmic 20 41 transmembrane 42 46 non-cytoplasmic 47 66 transmembrane 67 86 cytoplasmic 87 107 transmembrane 108 124 non-cytoplasmic 125 145 transmembrane 146 154 cytoplasmic 155 179 transmembrane 180 199 non-cytoplasmic 200 222 transmembrane 223 241 cytoplasmic 242 263 transmembrane 264 287 non-cytoplasmic 288 309 transmembrane 310 335 cytoplasmic 336 355 transmembrane 356 360 non-cytoplasmic 361 381 transmembrane 382 401 cytoplasmic 402 424 transmembrane 425 429 non-cytoplasmic 430 450 transmembrane 451 464 cytoplasmic
Input: >Pf1N1B4_1639 MSSSQSSSNGLEQGLKPRHVTMLSIAGVIGAGLFVGSGHAIAAAGPAVLLAYAAAGALVV LVMRMLGEMAVASPDTGSFSTYADRAIGHWAGFTIGWLYWWFWVLVIPLEANAAATILHA WFPNVAIWAFTLVITLLLTATNLFSVKNYGEFEFWFALVKVIAIIGFIGLGILAIFGFLP TSQVSGVSHLFDTQGFLPNGMGAVLGAILTTMFSFMGTEIVTIAAAESKNPGQQISKATN SVIWRIGLFYLVSIFIVVALVPWNDPILASVGSYQTVLERMGIPNAKLIVDIVVLVAVTS CLNSALYTASRMMFSLGKRGDAPAVSQRTNSSGTPYWAVMLSTAAAFLAVFANYVAPAAV FEFLLASSGAIALLVYLVIAISQLRMRKQRMARGEKIAFSMWLFPGLTYAVIVFIVAALT IMLFQEAHRVEILATGLLSALVVAAGLLVARRRRNEKLTAAIAR
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server